about
Ubiquitin C-terminal hydrolase-L3 regulates Smad1 ubiquitination and osteoblast differentiationSystematic analysis of dimeric E3-RING interactions reveals increased combinatorial complexity in human ubiquitination networksIdentification, analysis, and prediction of protein ubiquitination sitesCrystal structure of the ubiquitin-like small archaeal modifier protein 2 fromHaloferax volcaniiEssentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3Mechanisms of pseudosubstrate inhibition of the anaphase promoting complex by Acm1.Trial Watch: Proteasomal inhibitors for anticancer therapyRegulation of translesion DNA synthesis: Posttranslational modification of lysine residues in key proteinsLoss of nuclear factor E2-related factor 1 in the brain leads to dysregulation of proteasome gene expression and neurodegenerationNuclear factor-erythroid 2-related factor 1 regulates expression of proteasome genes in hepatocytes and protects against endoplasmic reticulum stress and steatosis in miceAntiviral activity of a small molecule deubiquitinase inhibitor occurs via induction of the unfolded protein responseRoles of protein ubiquitination and degradation kinetics in biological oscillationsSmall molecule deubiquitinase inhibitors promote macrophage anti-infective capacityMass Spectrometric Analysis of Lysine Ubiquitylation Reveals Promiscuity at Site LevelDefects in cellular sorting and retroviral assembly induced by GGA overexpressionConstruction of a large scale integrated map of macrophage pathogen recognition and effector systems.Novel approach for characterizing ubiquitin E3 ligase function.Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease.Inhibition of Siah2 ubiquitin ligase by vitamin K3 (menadione) attenuates hypoxia and MAPK signaling and blocks melanoma tumorigenesisPathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseasesTargeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation.Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future.The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy.Development of peptide-based reversing agents for p-glycoprotein-mediated resistance to carfilzomibLoop 7 of E2 enzymes: an ancestral conserved functional motif involved in the E2-mediated steps of the ubiquitination cascade.The ubiquitin-proteasome system and assays to determine responses to inhibitors.Glucocorticoid-induced Leucine zipper 1 stimulates the epithelial sodium channel by regulating serum- and glucocorticoid-induced kinase 1 stability and subcellular localization.Biodistribution and Efficacy Studies of the Proteasome Inhibitor BSc2118 in a Mouse Melanoma ModelPSMB9 codon 60 polymorphisms have no impact on the activity of the immunoproteasome catalytic subunit B1i expressed in multiple types of solid cancerImproved quantitative mass spectrometry methods for characterizing complex ubiquitin signals.Development of inhibitors in the ubiquitination cascade.Biophysical studies on interactions and assembly of full-size E3 ubiquitin ligase: suppressor of cytokine signaling 2 (SOCS2)-elongin BC-cullin 5-ring box protein 2 (RBX2).Reduced association of anti-apoptotic protein Mcl-1 with E3 ligase Mule increases the stability of Mcl-1 in breast cancer cells.A spectrophotometric assay for conjugation of ubiquitin and ubiquitin-like proteins.Ubiquitin-independent proteasomal degradation during oncogenic viral infections.Unraveling the ubiquitome of the human malaria parasite.A variant of PSMD6 is associated with the therapeutic efficacy of oral antidiabetic drugs in Chinese type 2 diabetes patients.The ubiquitin-proteasome system meets angiogenesis.System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes.Substituted quinolines as noncovalent proteasome inhibitors.
P2860
Q24298405-4F890C50-FB48-497B-9493-17F8B929BD86Q24312708-0770F9DE-4E7B-4535-8848-6DB57A37423FQ24624622-8DED9D2D-D1F7-49A2-9EAB-703A83828D1AQ27678888-78AA0084-4DDE-4550-BDD6-A93D6C293731Q27679081-48789C0F-535F-4B4B-9DA4-F43B901B0A7AQ27936984-6FF262B9-F2BA-4864-AF37-6282D2CE6339Q28082910-376BECCB-F9CC-464F-9580-A7DD9B72A529Q28087183-C13879A6-8C37-4649-B342-FA4681804296Q28236609-B4AE9976-CE0D-4C05-91D5-D2C9D8831B0BQ28291312-92383B62-DA9D-4E25-BC99-BA7019213BD4Q28481001-CEC29433-5889-4E7B-903B-64EF702204D8Q28482220-A4913895-1B43-470C-AF09-C8498FC2631BQ28541638-8B382A70-2AF7-4EE3-A1F7-532B67B750EBQ30002367-A5DBB052-33C9-412A-8BD2-849F98A361C6Q33507450-25FF9ECE-6C47-4471-B192-3654A041597AQ33578288-8F1A93F0-CDF7-473C-8CCB-06EF528D35BFQ33701445-4FA28F3A-FFD1-442E-B8EE-284D372DB98EQ33764254-BE7F0566-5165-4AC9-932C-33D80A259009Q33825403-5DE598F6-F5D2-412D-AE6B-FBA3C7762ACFQ33909288-8EDCF2CC-927C-4F05-AF4C-F95AA4782ED9Q34043797-E1210DA4-292F-44B7-828C-795065248E1EQ34195083-814AC8ED-CCEB-465E-8730-EBE9037735B8Q34202686-F17058F8-B045-4B3A-B59B-FFF40955D23FQ34317307-E1F2E2D2-ED2B-4D89-97F5-17876E066D79Q34345185-0B8B3B8A-9800-4F0F-93CB-E55669A1A322Q34347848-F811888E-7FE5-4949-A142-2D0AD8C0B99CQ34400942-F2965670-D8A7-469C-9842-C4277AC27E12Q34478543-EABCF8BC-999B-4003-92A2-106BCB4F9F67Q34989194-DC7FDCF5-1D9E-48A5-AEEC-0EE9741ABA09Q34994326-3DFAB945-8A4B-4558-9DE6-AA59DFA1E9B1Q35044801-D458AEA1-E00E-44E3-A2DA-EFEE25191A43Q35080292-4C0BEF57-1694-4E04-A9FB-23DBE21303D4Q35212637-A391EF9C-B24D-4A18-8D86-F6C1A15BF8D6Q35226580-2A56F0A6-C35A-4A31-93C8-189BF1EE605AQ35354212-C5FB8FBD-E72D-4CA4-81D9-5E66B9A8A9F1Q35562655-1814E042-3DA3-43AE-959A-A4BD7825852DQ35664025-833F01BA-8686-44A5-87CA-4BA16B3A36B1Q35815625-A116C00B-2C22-4BA2-8F83-D685B1B1EAB4Q35947378-2FA2E4C1-5B47-4723-8FA6-8404212BE5C6Q35998619-7035E0B4-78C7-4C2D-8355-3DE9226DB6A4
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The ubiquitin system, disease, and drug discovery.
@ast
The ubiquitin system, disease, and drug discovery.
@en
type
label
The ubiquitin system, disease, and drug discovery.
@ast
The ubiquitin system, disease, and drug discovery.
@en
prefLabel
The ubiquitin system, disease, and drug discovery.
@ast
The ubiquitin system, disease, and drug discovery.
@en
P2860
P921
P1433
P1476
The ubiquitin system, disease, and drug discovery.
@en
P2093
Matthew D Petroski
P2860
P2888
P356
10.1186/1471-2091-9-S1-S7
P478
P577
2008-10-21T00:00:00Z
P6179
1012982820